Evaluating and improving the quality of care in rheumatic disease

Expert Review of Pharmacoeconomics and Outcomes Research

Volumn 4, Issue 4, 2004, Pages 429-439

  Curtis, Jeffrey R ^a   Saag, Kenneth G ^a  

^a UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

Author keywords

Process of care; Quality; Quality indicators; Rheumatic disease

Indexed keywords

ANTIRHEUMATIC AGENT; CORTICOSTEROID; GLUCOCORTICOID; NONSTEROID ANTIINFLAMMATORY AGENT; PROTON PUMP INHIBITOR;

CLINICAL RESEARCH; CORTICOSTEROID INDUCED OSTEOPOROSIS; DRUG FATALITY; EVALUATION; GASTROINTESTINAL SYMPTOM; GASTROINTESTINAL TOXICITY; HEALTH CARE ACCESS; HEALTH CARE DELIVERY; HEALTH CARE QUALITY; HUMAN; MEASUREMENT; MUSCULOSKELETAL DISEASE; OSTEOARTHRITIS; PATIENT EDUCATION; PATIENT SATISFACTION; PRACTICE GUIDELINE; PRIMARY MEDICAL CARE; PUBLIC HEALTH SERVICE; QUALITY OF LIFE; RETROSPECTIVE STUDY; REVIEW; RHEUMATIC DISEASE; RHEUMATOID ARTHRITIS; RISK REDUCTION; STANDARDIZATION; TREATMENT OUTCOME;

EID: 4444338228     PISSN: 14737167     EISSN: None     Source Type: Journal    
DOI: 10.1586/14737167.4.4.429     Document Type: Review

References (97)

1. Levit K, Smith C, Cowan C, Sensenig A, Catlin A. Health spending rebound continues in 2002. Health Affairs 23(1), 147-159 (2004).
2. Cisternas M, Yelin E, Trupin L, Murphy L, Helmick C. Direct and indirect costs of arthritis and other rheumatic conditions, United States, 1997. MMWR 52(46), 1124-1127 (2003).
3. Kolata G. Johns Hopkins death brings halt to US-finances human studies. NY Times 20, A1-A18 (2001).
4. Leape L. Institute of Medicine - Crossing the Quality Chasm: a New Health System for the 21st Century. National Academy Press, Washington DC, USA (2001).
5. McGlynn E, Asch S, Adams J et al. The quality of healthcare delivered to adults in the United States. N. Engl. J. Med. 348(26), 2635-2645 (2003).
6. Jencks S, Cuerdon T, Burwen D, Fleming B, Houck P, Kussmaul A. Quality of medical care delivered to Medicare beneficiaries: a profile at state and national levels. JAMA 284, 1670-1676 (2000).
7. Centers for Disease Control and Prevention. Influenza and pneumococcal immunization rates among adults age greater than or equal to 65 years - United States. MMWR 47, 797-805 (1998).
8. Lohr K. Institute of Medicine - Medicare: a Strategy for Quality Assurance. Volume 21. National Academy Press, Washington DC, USA (1990).
9. Donabedian A. Evaluating the quality of medical care. Milbank Mem. Fund Q. 44, 166-206 (1966).
10. American College of Rheumatology Guidelines for the management of rheumatoid arthritis. Arthritis Rheumatism 46(2), 328-346 (2002).
11. Sokka T, Pincus T. Most patients receiving routine care for rheumatoid arthritis in 2001 did not meet inclusion criteria for most recent clinical trials or american college of rheumatology criteria for remission. J. Rheumatol. 30(6), 1138-1146 (2003).
12. Iezzoni L. The risks of risk adjustment. JAMA 278(19), 1600-1607 (1997).
13. Yazici Y, Erkan D, Pager S. Monitoring by rheumatologists for methotrexate, etanercept, infliximab and anakinra associated adverse events. Arthritis Rheumatism 48, 2769-2772 (2003).
14. Kremer J, Alarcon G, Lightfoot R, Willkens R, Furst D, Williams H. Methotrexate for rheumatoid arthritis: suggested guidelines for monitoring liver toxicity. Arthritis Rheumatism 37, 317-328 (1994).
15. Solomon D, Katz J, Jacobs J, La Tourette A, Coblyn J. Management of glucocorticoid induced osteoporosis in patients with rheumatoid arthritis: rates and predictors of care in an academic rheumatology practice. Arthritis Rheumatism 46, 3136-3142 (2002).
16. Mudano A, Allison J, Hill J, Rothermel T, Saag K. Variations in glucocorticoid induced osteoporosis prevention in a managed care cohort. J. Rheumatol. 28, 1298-1305 (2001).
17. Harrington JT, Broy S, Derosa A, Licata A, Shewmon D. Hip fracture patients are not treated for osteoporosis: a call to action. Arthritis Rheumatism 47(6), 651-654 (2002).
18. NIAMS. Handout on Health: Osteoarthritis. Report No. NIH Publication No. 02-4617 (2002).
19. Glazier R, Badley E, Wright J, Coyte P, Williams JI, Harvey B. Patients and provider factors related to comprehensive arthritis care in a community setting in Ontario, Canada. J. Rheumatol. 30, 1846-1850 (2003).
20. Pincus T. Guidelines for monitoring of methotrexate therapy: evidence based medicine outside of clinical trials. Arthritis Rheumatism 48(10), 2706-2709 (2003).
21. American College of Rheumatology Ad Hoc Committee on glucocorticoid induced osteoporosis: recommendations for the prevention and treatment of glucocorticoid induced osteoporosis: 2001 update. Arthritis Rheumatism 44, 1496-1503 (2001).
22. Skinner J, Weinstein J, Sporer S, Wennberg J. Racial, ethnic and geographic disparaities in rates of knee arthroplasty among Medicare patients. N. Engl. J. Med. 349(14), 1350-1359 (2003).
23. Mikuls T, Mudano ALP, Saag K. The association of race/ethnicity with the receipt of traditional and alternative arthritis-specific healthcare. Med. Care 41(11), 1233-1239 (2003).
24. Mudano A, Casebeer L, Patino F et al. Racial disparaties in osteoporosis prevention in a managed care population. Southern Med. J. 96(5), 445-451 (2003).
25. Hodgson T, Cohen A. Medical expenditures for major diseases, 1995. Healthcare Financ. Rev. 21, 119-164 (1999).
26. Shekelle PG, MacLean CH, Morton SC, Wenger NS. Assessing care of vulnerable elders: methods for developing quality indicators. Ann. Intern. Med. 135, 647-652 (2001).
27. NOF. Osteoporosis disease statistics. (2003).
28. Wenger NS, Solomon D, Roth C et al. The quality of medical care provided to vulnerable community dwelling older patients. Ann. Intern. Med. 139, 740-747 (2003).
29. Pencharz J, Li X, Li L. Quality of care provided to a community based sample of patients with osteoarthritis. Arthritis Rheumatism 46(9), S627 (2002).
30. Mikuls T, Allison J, Olivieri J, Patino F, Maclean C, Saag K. The development of quality indicators in gout therapy. Arthritis Rheumatism 46(9), S625 (2002).
31. Saag K, Olivieri J, Patino F, Mikuls T, Allison J, Maclean C. Measuring quality in arthritis care: the Arthritis Foundation's quality indicator set for analgesics. Arthritis Rheumatism (2004) (In Press).
32. Blot W, McLaughlin J. Over-the-counter nonsteroidal anti-inflammatory drugs and risk of gastrointestinal bleeding. J. Epidemiol. Biostat. 5, 137-143 (2000).
33. Cham E, Hall L, Ernst A, Weiss S. Awareness and use of over the counter pain medications: a survey of emergency department patients. Southern Med. J. 95(5), 529-535 (2002).
34. Singh G, Triadafilopoulos G. Epidemiology of NSAID induced gastrointestinal complications. J. Rheumatol. 26 S56, 18-24 (1999).
35. Singh G, Ramey D, Morfeld D, Shi H, Hatoum H, Fries J. Gastrointestinal tract complications of nonsteroidal anti-inflammatory drug treatment in rheumatoid arthritis. A prospective observational cohort study. Arch. Int. Med. 156(14), 1530-1536 (1996).
36. Maclean C, Saag K, Solomon D, Morton S, Sampsel S, Klippel J. Measuring quality in arthritis care: methods for developing the Arthritis Foundation's quality indicator set. Arthritis Rheumatism 51(2), 193-202 (2004).
37. Jobanputra P, Pugh M, Arthur V, Holmes G, Spannuth F, Griffiths P. An index to assess quality of care for NSAID users with arthritis or musculoskeletal pain. Arthritis Rheumatism 48(9), S218 (2003).
38. Kohn L, Corrigan J, Donaldson M. To Err Is Human: Building a Safer Health System. National Academy Press, Washington DC, USA (2000).
39. Brennan T. The Institute of Medicine Report on medical errors - could it do harm? N. Engl. J. Med. 342, 1123-1125 (2000).
40. Campion E. A death at duke. N. Engl. J. Med. 348(12), 1083-1084 (2003).
41. Woolf S. Patient safety is not enough: targeting quality improvements to optimize the health of the population. Ann. Intern. Med. 140, 33-36 (2004).
42. National Committee for Quality Assurance N. State of healthcare quality. (2003).
43. O'Day B, Palsbo S, Dhont K, Scheer J. Health plan selection criteria by people with impaired mobility. Med. Care. 40(9), 725-728 (2002).
44. Jewett J, Hibbard J. Comprehension of quality care indicators: differences by insurance status. Healthcare Financ. Rev. 18(1), 75-95 (1996).
45. Davies H, Washington A, Bindman A. Healthcare report cards: implications for vulnerable patient groups and the organizations providing them care. J. Health Polit Policy Law 27(3), 379-399 (2002).
46. Wedig G, Tai-Seale M. The effect of report cards on consumer choice in the health insurance market. J. Health Econ. 21, 1031-1048 (2002).
47. Kerr E, Smith D, Hogan M et al. Building a better quality measure: are some patients with poor quality actually getting good care? Med. Care 1(10), 1173-1182 (2003).
48. Casalino L. The unintended consequences of measuring quality on the quality of medical care. N. Engl. J. Med. 341(15), 1147-150 (1999).
49. Allison J. Quality assessment tools: incremental advance or paradigm shift? Med. Care 41(5), 575-578 (2003).
50. Rupp I, Boshuizen H, Jacobi C, Dinant H, Van Den Bos G. Comorbidity in patients with rheumatoid arthritis: effect on health related quality of life. J. Rheumatol. 31(1), 58-65 (2004).
51. Roman M, Shanker B, Davis A, Lockshin M, Sammaritano L, Simantov R. Prevalence and correlates of accelerated atherosclerosis in systemic lupus erythematosus. N. Engl. J. Med. 349(25), 2399-2406 (2003).
52. Asanuma Y, Oeser A, Shintani A et al. Premature coronary artery atherosclerosis in systemic lupus erythematosus. N. Engl. J. Med. 349(25), 2407-2415 (2003).
53. Solomon DH, Karlson E, Rimm E, Cannuscio C, Mandl L, Manson J. Cardiovascular mobidity and mortality in women diagnosed with rheumatoid arthritis. Circulation 107, 1303-1307 (2003).
54. Esdaile J, Abrahamowicz M, Grodzicky T. Traditional Framingham risk factors fail to fully account for accelerated atherosclerosis in systemic lupus erythematosus. Arthritis Rheumatism 44, 2331-2337 (2001).
55. Solomon DH, Curhan G, Karlson E. Cardiovascular risk factors and rheumatoid arthritis. Arthritis Rheumatism 48(9), S707 (2003).
56. Kremers H, Nicola P, Crowson C, Ballman K, Gabriel S. Cardiovascular risk profile and mortality in a population based cohort of rheumatoid arthritis patients over a 40 year period. Arthritis Rheumatism 48(9), S706 (2003).
57. Al-Herz A, Ensworth S, Shojania K, Esdaile J. Cardiovascular risk factor screening in systemic lupus erythematosus. J. Rheumatol. 30, 493-496 (2003).
58. MacLean CH, Louie R, Leake B et al. Quality of care for patients with rheumatoid arthritis. JAMA 284(8), 984-992 (2000).
59. Lin E, Katon W, Von Korff M et al. Effects of improving depression care on pain and functional outcomes among older adults with arthritis: a randomized controlled trial. JAMA 290(18), 2428-2429 (2003).
60. Wang B. Managing comorbidides in the rheumatic diseases: the new reality. J. Rheumatol. 30(5), 1-3 (2003).
61. Bero L, Grilli R, Grimshaw J, Harvey E, Oxman A, Thompson M. Closing the gap between research and practice: an overview of systematic reviews of interventions to promote the implementation of research findings. Br. Med. J. 317, 465-458 (1998).
62. Kiefe C, Allison J, Williams O, Person S, Weaver M, Weissman N. Improving quality improvement: a randomized trial of achievable benchmark of care feedback. JAMA 285(22), 2871-2879 (2001).
63. Berwick D. Developing and testing changes in delivery of care. Ann. Intern. Med. 128(8), 651-656 (1998).
64. Berwick D. Disseminating innovations in healthcare. JAMA 239, 1969-1975 (2003).
65. Casarett D, Karlawish J, Sugarman J. Determining when quality improvement initiatives should be considered research: proposed criteria and potential implications. JAMA 283, 2275-2280 (2000).
66. Harrington JT. A view of our future: the case for redesigning rheumatology practice. Arthritis Rheumatism 49(5), 716-719 (2003).
67. Harrington JT, Barash H, Day S. Improving osteoporosis management of fragility fracture patients with a rheumatology based osteoporosis care service. Arthritis Rheumatism 48(9), S84 (2003).
68. Newman E, Ayoub W, Starkey R, Diehl J, Wood G. Osteoporosis disease management in a rural healthcare population: hip fracture reduction and reduced costs in postmenopausal women after 5 years. Osteoporosis Int. 14, 146-151 (2003).
69. Pincus T, Gibofsky A, Weinblatt M. Urgent care and tight control of rheumatoid arthritis as in diabetes and hypertension: better treatments but a shortage of rheumatologists. Arthritis Rheumatism 46(4), 851-854 (2002).
70. Koening C, Cannon G. Delay in new and established patient appointment times in rheumatology practice: a potential measure of rheumatology workforce. Arthritis Rheumatism 48(9), S220 (2003).
71. Unruh L, Jordan J, Overmiller J, Paolo A, Welch K, Lindsley H. New patient scheduling practices of rheumatologists. Arthritis Rheumatism 48(9), S220 (2003).
72. Harrington JT, Dopf C, Chalgren C. Implementing guidelines for interdisciplingary care of low back pain: a critical role for pre appointment management of specialty referrals. J. Qual. Improvement 27(12), 651-663 (2001).
73. Harrington JT, Walsh M. Preappointment management of new patient referrals in rheumatology: a key strategy for improving healthcare delivery. Arthritis Care Res. 45, 295-300 (2001).
74. Murray M, Berwick D. Advanced access: reducing waiting and delays in primary care. JAMA 289(8), 1035-1040 (2003).
75. Newman E, Harrington T, Oleginski T, Perruquet J. The rheumatologist can see you today: successful implementation of an open access model in a rheumatology practice. Arthritis Rheumatism 46(9), S372 (2002).
76. Van Campen C, Sixma H, Kerssens J, Peters L. Quality of care and patient satisfaction: a review of measuring instruments. Med. Care Res. Rev. 52, 109-133 (1995).
77. Van Campen C, Sixma H, Kerssens J, Peters L, Rasker J. Assessing patients' priorities and perceiptions of the quality of healthcare: the development of the quote rheumatic patients instrument. Br. J. Rheumatol. 37, 362-368 (1998).
78. Jacobi C, Boshuizen H, Rupp I, Dinant H. Quality of rheumatoid arthritis care: the patient's perspective. Int. J. Qual. Healthcare 16(1), 73-81 (2004).
79. Kirwan J, Heiberg T, Hewlett SA et al. Outcomes from the patient perspective workshop at OMERACT 6. J. Rheumatol. 30, 868-872 (2003).
80. Hewlett SA. Patients and clinicians have different perspectives on outcomes in arthritis. J. Rheumatol. 30, 877-879 (2003).
81. Kwoh C, O'Connor G, Regan-Smith M. Concordance between clinician and patient assessment of physical and mental health status. J. Rheumatol. 19, 1031-1037 (1992).
82. Wallace K, Riedel A, Joseph-Ridge N, Nelson M, MacDonald P, Becker M. Compliance with allopurinol therapy among managed care enrollees with gout: a retrospective analysis of administrative claims. Arthritis Rheum. 48(9), S611 (2003).
83. de Klerk E, van der Heijde D, Landewe R, van der Tempel H, Urquhart J, van der Linden S. Patient compliance in rheumatoid arthritis, polymyalgia rheumatica and gout. J. Rheumatol. 30(1), 44-54 (2003).
84. Dacus J, Parker C, Cabrera M, Rennie T, Rubal B. No cost method to improve compliance with methotrexate monitoring in rheumatoid arthritis. Arthritis Rheumatism 48(9), S460 (2003).
85. Kim H, Oh J. Adherence to diabetes control recommendations: impact of nurse telephone calls. J. Adv. Nurs. 44(3), 256-261 (2003).
86. Jerant A, Azari R, Martinez C, Nesbitt T. A randomized trial of telenursing to reduce hospitalization for heart failure: patient-centered outcomes and nursing indicators. Home Healthcare Serv. Q. 22(1), 1-20 (2003).
87. Greenwald K, Bardwell A, Kishner P, Malinak J, Lewiecki EM, Rude R. Increasing patient compliance with osteoporosis treatment by using a more meaningful report form. Arthritis Rheumatism 48(9), S426 (2003).
88. Tunis S, Stryer D, Clancy C. Practical clinical trials: increasing the value of clinical research for decision making in clinical and health policy. JAMA 290(12), 1624-32 (2003).
89. Moseley J, O'Malley K, Petersen N. A controlled trial of arthroscopic survery for osteoarthritis of the knee. N. Engl. J. Med. 347, 81-88 (2002).
90. Evans A, Jensen M, Kip K, DeNardo A. Vertebral compression fractures: pain reduction and improvement in functional mobility after percutaneous polymethylmethacrylate vertebroplasty retrospective report of 245 cases. Radiology 226, 366-372 (2003).
91. Uppin A, Hirsch J, Centenera L. Occurrence of new vertebral body fracture after percutaneous vertebroplasty in patients with osteoporosis. Radiology 226, 119-124 (2003).
92. Katz J, Barrett J, Liang M et al. Sensitivity and positive predictive value of Medicare Part B physician claims for rheumatologic diagnoses and procedures. Arthritis Rheumatism 40(9), 1594-1600 (1997).
93. Losina E, Barrett J, Baron J, Katz J. Accuracy of Medicare claims data for rheumatologic diagnoses in total hip replacement recipients. J. Clin. Epidemiol. 56, 515-519 (2003).
94. Kwoh CK, Starz T, Osial T, Wasko M. Variations in treatment of rheumatoid arthritis by rheumatologists and non-rheumatologists. Arthritis Rheumatism 46(9), S334 (2002).
95. Emery P, Breedveld F, Dougados M, Kalden J, Schiff M, Smolen J. Early referral recommendation for newly diagnosed rheumatoid arthritis: evidence-based development of a clinical guide. Ann. Rheum. Dis. 61(4), 290-297 (2002).
96. Houssien D, Scott D. Early referral and outcome in rheumatoid arthritis. Scand. J. Rheumatol. 27(4), 300-302 (1998).
97. Jansen L, van der Horst-Bruinsma I, van Schaardenburg D, Bezemer P, Dijkmans B. Predictors of radiographic joint damage in patients with early rheumatoid arthritis. Ann. Rheumatic Dis. 60(10), 924-927 (2001).